Financhill
Back

ITeos Therapeutics Quote, Financials, Valuation and Earnings

ITeos Therapeutics Price Quote

$14.65
-0.24 (-1.61%)
(Updated: June 25, 2024 at 6:55 PM ET)

ITeos Therapeutics Key Stats

Buy
60
ITeos Therapeutics (ITOS) is a Buy

Day range:
$14.57 - $15.02
52-week range:
$8.20 - $18.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.17
P/B ratio:
0.99%

Volume:
322.7K
Avg. volume:
610.2K
1-year change:
8.45%
Market cap:
$537.9M
Revenue:
$12.6M
EPS:
$-3.78

How Much Does ITeos Therapeutics Make?

Data Unavailable

Is ITeos Therapeutics Growing As A Company?

Data Unavailable

ITeos Therapeutics Stock Price Performance

What Is ITeos Therapeutics 52-Week High & Low?

ITeos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ITeos Therapeutics?

Is ITeos Therapeutics Cash Flow Positive?

  • What Is ITOS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$109.6M
  • What Is ITeos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $557K
  • What Is ITeos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $34.8M

ITeos Therapeutics Return On Invested Capital

Data Unavailable

ITeos Therapeutics Earnings Date & Stock Price

ITeos Therapeutics Competitors

ITeos Therapeutics Dividend Yield

Data Unavailable

ITeos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -13.96%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 35.40
Upside from Last Price: 137.74%

Major Shareholders

  • How many ITOS shares are owned by institutional investors?
    45.7M ITOS shares are owned by institutional investors
  • How many ITOS shares are owned by insiders?
    288.2K ITOS shares are owned by insiders